A Comparison of the Excellent BRASSS-V Drape™ and an Indirect Blood Measurement Protocol for the Measurement of Blood Loss During ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2005-2007

ABSTRACT

Postpartum hemorrhage is one of the most common causes of maternal mortality and serious maternal morbidity, especially in the developing world. In India, hemorrhage is a major cause of maternal mortality: A study by the Register General in 1993 showed that 23 percent of all maternal deaths in rural areas were caused by hemorrhage (Sibley, 2005). The measurement of postpartum blood loss and identification of postpartum hemorrhage are important measures in efforts to prevent and treat postpartum hemorrhage. In recent years, researchers have employed several different methods to measure blood loss in hospital and community-based birth settings. Although research has demonstrated that these laboratory measures are more accurate then visual estimation techniques, no studies have explicitly documented the systematic differences (if any) among different collection modalities. Moreover, only a few of these studies have correlated measured blood loss with changes in hemoglobin levels experienced between the antepartum and postpartum period. The aim of this study is to compare variations in the measurement of blood loss obtained using two popular measurement methods: the Excellent BRASSS-V Drape™ and a modified version of the blood collection method developed by the World Health Organization (WHO). Detailed Description Postpartum hemorrhage is one of the most common causes of maternal mortality and serious maternal morbidity, especially in the developing world. In India, hemorrhage is a major cause of maternal mortality: A study by the Register General in 1993 showed that 23 percent of all maternal deaths in rural areas were caused by hemorrhage (Sibley, 2005). The measurement of postpartum blood loss and identification of postpartum hemorrhage are important measures in efforts to prevent and treat postpartum hemorrhage. However, visual estimation of postpartum hemorrhage often leads to underestimation of blood loss and subsequent delays in the seeking or provision of appropriate treatment. In recent years, researchers have employed several different methods to measure blood loss in hospital and community-based birth settings. Although research has demonstrated that these laboratory measures are more accurate then visual estimation techniques, no studies have explicitly documented the systematic differences (if any) among different collection modalities. Moreover, only a few of these studies have correlated measured blood loss with changes in hemoglobin levels experienced between the antepartum and postpartum period. The aim of this study is to compare variations in the measurement of blood loss obtained using two popular measurement methods: the Excellent BRASSS-V Drape™ and a modified version of the blood collection method developed by the World Health Organization (WHO). We propose a randomized prospective study to compare the measurement of blood loss during the third stage of labor with two different methods: the modified WHO blood measurement protocol and the Excellent BRASSS-V Drape™. Upon admission in the labor ward, study staff will approach all delivering women about participation in the study and seek informed consent. Blood loss will be measured for all consenting women with vaginal deliveries. Women who agree to participate will be randomized to one of two blood collection techniques: a modified version of the WHO blood measurement protocol or the Excellent BRASSS-V Drape™. Blood loss will be measured from immediately after delivery and cord clamping for a period of at least one hour or until active bleeding stops. The blood loss will then be quantified by the study staff and recorded on the study form. Women will receive the facility's standard care for the management of the third stage of labor and, if applicable, treatment of PPH. Measures of postpartum hemoglobin levels will be taken at admission for delivery and twenty-four hours post-delivery for a randomly selected sub-set of study participants. Besides the measurement of blood loss and the regular measurement of hemoglobin for a sub-sample of participants, there will be no change to the hospital's standard procedures for labor and delivery. More... »

URL

https://clinicaltrials.gov/show/NCT01885845

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3177", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Postpartum hemorrhage is one of the most common causes of maternal mortality and serious maternal morbidity, especially in the developing world. In India, hemorrhage is a major cause of maternal mortality: A study by the Register General in 1993 showed that 23 percent of all maternal deaths in rural areas were caused by hemorrhage (Sibley, 2005). The measurement of postpartum blood loss and identification of postpartum hemorrhage are important measures in efforts to prevent and treat postpartum hemorrhage. In recent years, researchers have employed several different methods to measure blood loss in hospital and community-based birth settings. Although research has demonstrated that these laboratory measures are more accurate then visual estimation techniques, no studies have explicitly documented the systematic differences (if any) among different collection modalities. Moreover, only a few of these studies have correlated measured blood loss with changes in hemoglobin levels experienced between the antepartum and postpartum period. The aim of this study is to compare variations in the measurement of blood loss obtained using two popular measurement methods: the Excellent BRASSS-V Drape\u2122 and a modified version of the blood collection method developed by the World Health Organization (WHO).\n\nDetailed Description\nPostpartum hemorrhage is one of the most common causes of maternal mortality and serious maternal morbidity, especially in the developing world. In India, hemorrhage is a major cause of maternal mortality: A study by the Register General in 1993 showed that 23 percent of all maternal deaths in rural areas were caused by hemorrhage (Sibley, 2005). The measurement of postpartum blood loss and identification of postpartum hemorrhage are important measures in efforts to prevent and treat postpartum hemorrhage. However, visual estimation of postpartum hemorrhage often leads to underestimation of blood loss and subsequent delays in the seeking or provision of appropriate treatment. In recent years, researchers have employed several different methods to measure blood loss in hospital and community-based birth settings. Although research has demonstrated that these laboratory measures are more accurate then visual estimation techniques, no studies have explicitly documented the systematic differences (if any) among different collection modalities. Moreover, only a few of these studies have correlated measured blood loss with changes in hemoglobin levels experienced between the antepartum and postpartum period. The aim of this study is to compare variations in the measurement of blood loss obtained using two popular measurement methods: the Excellent BRASSS-V Drape\u2122 and a modified version of the blood collection method developed by the World Health Organization (WHO). We propose a randomized prospective study to compare the measurement of blood loss during the third stage of labor with two different methods: the modified WHO blood measurement protocol and the Excellent BRASSS-V Drape\u2122. Upon admission in the labor ward, study staff will approach all delivering women about participation in the study and seek informed consent. Blood loss will be measured for all consenting women with vaginal deliveries. Women who agree to participate will be randomized to one of two blood collection techniques: a modified version of the WHO blood measurement protocol or the Excellent BRASSS-V Drape\u2122. Blood loss will be measured from immediately after delivery and cord clamping for a period of at least one hour or until active bleeding stops. The blood loss will then be quantified by the study staff and recorded on the study form. Women will receive the facility's standard care for the management of the third stage of labor and, if applicable, treatment of PPH. Measures of postpartum hemoglobin levels will be taken at admission for delivery and twenty-four hours post-delivery for a randomly selected sub-set of study participants. Besides the measurement of blood loss and the regular measurement of hemoglobin for a sub-sample of participants, there will be no change to the hospital's standard procedures for labor and delivery.", 
    "endDate": "2007-09-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01885845", 
    "keywords": [
      "comparison", 
      "measurement protocol", 
      "blood loss", 
      "stage", 
      "vaginal delivery", 
      "hemorrhage", 
      "maternal mortality", 
      "maternal morbidity", 
      "world", 
      "India", 
      "register", 
      "maternal death", 
      "rural area", 
      "measurement", 
      "important measure", 
      "different method", 
      "hospital", 
      "setting", 
      "laboratory measure", 
      "estimation", 
      "systematic difference", 
      "collection", 
      "hemoglobin level", 
      "antepartum", 
      "Postpartum Period", 
      "variation", 
      "measurement method", 
      "modified version", 
      "blood collection", 
      "World Health Organization", 
      "underestimation", 
      "delay", 
      "provision", 
      "appropriate treatment", 
      "prospective study", 
      "third stage", 
      "labor", 
      "admission", 
      "study staff", 
      "woman", 
      "participation", 
      "informed consent", 
      "delivery", 
      "cord", 
      "period", 
      "study form", 
      "facility", 
      "standard care", 
      "management", 
      "Pph", 
      "Weight and Measure", 
      "twenty-four hour", 
      "sub-set", 
      "study participant", 
      "hemoglobin", 
      "sub-sample", 
      "standard procedure"
    ], 
    "name": "A Comparison of the Excellent BRASSS-V Drape\u2122 and an Indirect Blood Measurement Protocol for the Measurement of Blood Loss During Third Stage of Vaginal Delivery", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01885845"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00014.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.413472.7", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.46534.30", 
        "type": "Organization"
      }
    ], 
    "startDate": "2005-11-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/1471-2393-14-276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047964994", 
          "https://doi.org/10.1186/1471-2393-14-276"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01885845"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01885845'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01885845'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01885845'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01885845'


 

This table displays all metadata directly associated to this object as RDF triples.

82 TRIPLES      16 PREDICATES      74 URIs      66 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01885845 schema:about anzsrc-for:3177
2 schema:description Postpartum hemorrhage is one of the most common causes of maternal mortality and serious maternal morbidity, especially in the developing world. In India, hemorrhage is a major cause of maternal mortality: A study by the Register General in 1993 showed that 23 percent of all maternal deaths in rural areas were caused by hemorrhage (Sibley, 2005). The measurement of postpartum blood loss and identification of postpartum hemorrhage are important measures in efforts to prevent and treat postpartum hemorrhage. In recent years, researchers have employed several different methods to measure blood loss in hospital and community-based birth settings. Although research has demonstrated that these laboratory measures are more accurate then visual estimation techniques, no studies have explicitly documented the systematic differences (if any) among different collection modalities. Moreover, only a few of these studies have correlated measured blood loss with changes in hemoglobin levels experienced between the antepartum and postpartum period. The aim of this study is to compare variations in the measurement of blood loss obtained using two popular measurement methods: the Excellent BRASSS-V Drape™ and a modified version of the blood collection method developed by the World Health Organization (WHO). Detailed Description Postpartum hemorrhage is one of the most common causes of maternal mortality and serious maternal morbidity, especially in the developing world. In India, hemorrhage is a major cause of maternal mortality: A study by the Register General in 1993 showed that 23 percent of all maternal deaths in rural areas were caused by hemorrhage (Sibley, 2005). The measurement of postpartum blood loss and identification of postpartum hemorrhage are important measures in efforts to prevent and treat postpartum hemorrhage. However, visual estimation of postpartum hemorrhage often leads to underestimation of blood loss and subsequent delays in the seeking or provision of appropriate treatment. In recent years, researchers have employed several different methods to measure blood loss in hospital and community-based birth settings. Although research has demonstrated that these laboratory measures are more accurate then visual estimation techniques, no studies have explicitly documented the systematic differences (if any) among different collection modalities. Moreover, only a few of these studies have correlated measured blood loss with changes in hemoglobin levels experienced between the antepartum and postpartum period. The aim of this study is to compare variations in the measurement of blood loss obtained using two popular measurement methods: the Excellent BRASSS-V Drape™ and a modified version of the blood collection method developed by the World Health Organization (WHO). We propose a randomized prospective study to compare the measurement of blood loss during the third stage of labor with two different methods: the modified WHO blood measurement protocol and the Excellent BRASSS-V Drape™. Upon admission in the labor ward, study staff will approach all delivering women about participation in the study and seek informed consent. Blood loss will be measured for all consenting women with vaginal deliveries. Women who agree to participate will be randomized to one of two blood collection techniques: a modified version of the WHO blood measurement protocol or the Excellent BRASSS-V Drape™. Blood loss will be measured from immediately after delivery and cord clamping for a period of at least one hour or until active bleeding stops. The blood loss will then be quantified by the study staff and recorded on the study form. Women will receive the facility's standard care for the management of the third stage of labor and, if applicable, treatment of PPH. Measures of postpartum hemoglobin levels will be taken at admission for delivery and twenty-four hours post-delivery for a randomly selected sub-set of study participants. Besides the measurement of blood loss and the regular measurement of hemoglobin for a sub-sample of participants, there will be no change to the hospital's standard procedures for labor and delivery.
3 schema:endDate 2007-09-01T00:00:00Z
4 schema:keywords India
5 Postpartum Period
6 Pph
7 Weight and Measure
8 World Health Organization
9 admission
10 antepartum
11 appropriate treatment
12 blood collection
13 blood loss
14 collection
15 comparison
16 cord
17 delay
18 delivery
19 different method
20 estimation
21 facility
22 hemoglobin
23 hemoglobin level
24 hemorrhage
25 hospital
26 important measure
27 informed consent
28 labor
29 laboratory measure
30 management
31 maternal death
32 maternal morbidity
33 maternal mortality
34 measurement
35 measurement method
36 measurement protocol
37 modified version
38 participation
39 period
40 prospective study
41 provision
42 register
43 rural area
44 setting
45 stage
46 standard care
47 standard procedure
48 study form
49 study participant
50 study staff
51 sub-sample
52 sub-set
53 systematic difference
54 third stage
55 twenty-four hour
56 underestimation
57 vaginal delivery
58 variation
59 woman
60 world
61 schema:name A Comparison of the Excellent BRASSS-V Drape™ and an Indirect Blood Measurement Protocol for the Measurement of Blood Loss During Third Stage of Vaginal Delivery
62 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01885845
63 schema:sdDatePublished 2019-03-07T15:25
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N3dd9b0d838d54f2287d64251607daf89
66 schema:sponsor https://www.grid.ac/institutes/grid.413472.7
67 https://www.grid.ac/institutes/grid.46534.30
68 schema:startDate 2005-11-01T00:00:00Z
69 schema:subjectOf sg:pub.10.1186/1471-2393-14-276
70 schema:url https://clinicaltrials.gov/show/NCT01885845
71 sgo:license sg:explorer/license/
72 sgo:sdDataset clinical_trials
73 rdf:type schema:MedicalStudy
74 N3dd9b0d838d54f2287d64251607daf89 schema:name Springer Nature - SN SciGraph project
75 rdf:type schema:Organization
76 anzsrc-for:3177 schema:inDefinedTermSet anzsrc-for:
77 rdf:type schema:DefinedTerm
78 sg:pub.10.1186/1471-2393-14-276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047964994
79 https://doi.org/10.1186/1471-2393-14-276
80 rdf:type schema:CreativeWork
81 https://www.grid.ac/institutes/grid.413472.7 schema:Organization
82 https://www.grid.ac/institutes/grid.46534.30 schema:Organization
 




Preview window. Press ESC to close (or click here)


...